申请人:Hoffmann-La Roche Inc.
公开号:US20160222010A1
公开(公告)日:2016-08-04
This invention relates to novel 4-amino-imidazoquinoline compounds of the formula
wherein R
1
to R
4
are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are TLR agonists and may therefore be useful as medicaments for the treatment of diseases such as cancer or infectious diseases.
本发明涉及新型4-氨基咪唑喹啉化合物,其化学式如下:其中R1至R4如说明书和权利要求书中所定义,并且其药学上可接受的盐。这些化合物是TLR激动剂,因此可能作为治疗癌症或传染病等疾病的药物而有用。